|
|
SciBase announces outcome of rights issue of shares |
|
|
SciBase announces confirmed guarantee commitment in connection with ongoing rights issue |
|
|
Updated first day of trading in subscription rights and paid-up subscribed shares |
|
|
SciBase publishes information document regarding the rights issue |
|
|
SciBase receives additional order from Castle Biosciences, advancing the collaboration |
|
|
SCIBASE RESOLVES ON A RIGHTS ISSUE OF SHARES OF APPROXIMATELY SEK 58 MILLION |
|
|
Interim report |
|
|
SciBase announces changes in senior management |
|
|
SciBase Submits FDA 510(k) to Expand Nevisense into the Largest Skin Cancer Market |
|
|
First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase |
